NFKB1 and pulmonary emphysema: High Nrf2 expression counteracts the expression of pro-inflammatory genes by inhibiting NFκB and Nrf2 disruption aggravates the inflammatory response in models of sepsis, pleurisy, emphysema, and autoimmune diseases [56].